Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,650.00
Ask: 1,710.00
Change: 0.00 (0.00%)
Spread: 60.00 (3.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Asian data lifts stocks early on

Mon, 02nd Jul 2012 08:30

- Chinese, Japanese data comes in better than expected- RBS falls on Libor issues- Barclays Chairman resignsLondon's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment.China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9.Meanwhile, Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged ready.Investors will be looking ahead to policy decisions in both the UK and Europe around Thursday lunchtime. The Monetary Policy Committee (MPC) will be revealing its policy decision with the majority of economists expecting the Bank of England (BoE) to ramp up its asset purchase programme while keeping rates where they are.The European Central Bank (ECB) is anticipated to slash its main refinancing rate to a record-low 0.75%, compared with the current 1% level. 48 of the 71 economists surveyed by Reuters expect a reduction. FTSE 100: Banks continue to be dampened by Libor scandalRoyal Bank of Scotland (RBS) was a heavy faller after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked four of its traders last year over the alleged manipulation of interbank lending rates (London Interbank Offered Rate, or LIBOR). Some market reports said that some 10 traders were dismissed, citing unidentified sources.The news comes after last week's revelation that banking peer Barclays had been fined £290m after it was found attempting to control submissions for LIBOR to benefit its interest rate derivatives. The issue prompted the lender's Chairman Marcus Agius to resign this morning. He said he is "truly sorry" that the bank's customers, clients, employees and shareholders have been let down. Barclay swung between gains and losses early on following last week's sell-off.Insurance group Aviva rose after announcing that Chairman Lord Sharman retired as Chairman on June 30th. John McFarlane has taken over.Pharmaceuticals giant AstraZeneca edged higher after saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers.Sector peer GlaxoSmithKline also advanced after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012.Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team.Media giant WPP was in demand after announcing another acquisition; it has agreed to acquire the South Korean media planning and buying agency, Alchemedia, which will be merged into its GroupM Korea subsidiary.FTSE 250: Catlin falls after broker downgradeInsurance group Catlin fell after Jefferies downgraded the stock to 'hold' as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible."Oil and gas group SOCO International jumped after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. FTSE 100 - RisersStandard Chartered (STAN) 1,418.50p +2.46%Barclays (BARC) 166.00p +1.93%WPP (WPP) 786.00p +1.68%Aviva (AV.) 276.80p +1.54%Burberry Group (BRBY) 1,345.00p +1.51%Prudential (PRU) 748.50p +1.42%Lloyds Banking Group (LLOY) 31.50p +1.27%BP (BP.) 427.20p +1.24%G4S (GFS) 282.40p +1.18%Tullow Oil (TLW) 1,487.00p +1.16%FTSE 100 - FallersXstrata (XTA) 780.20p -2.30%Shire Plc (SHP) 1,796.00p -1.97%Glencore International (GLEN) 290.45p -1.73%Royal Bank of Scotland Group (RBS) 211.70p -1.67%Tesco (TSCO) 306.45p -1.16%Vodafone Group (VOD) 177.45p -1.00%Evraz (EVR) 258.30p -0.92%British Sky Broadcasting Group (BSY) 690.50p -0.86%Smith & Nephew (SN.) 632.50p -0.78%International Consolidated Airlines Group SA (CDI) (IAG) 158.30p -0.75%FTSE 250 - RisersSoco International (SIA) 302.80p +4.63%Imagination Technologies Group (IMG) 487.60p +4.50%Aquarius Platinum Ltd. (AQP) 47.40p +3.81%Essar Energy (ESSR) 125.90p +3.20%Invensys (ISYS) 229.00p +2.83%BH Global Ltd. USD Shares (BHGU) 11.45 +2.69%Fenner (FENR) 370.70p +2.60%Shanks Group (SKS) 78.30p +2.55%FirstGroup (FGP) 229.40p +2.27%TR Property Inv Trust (TRY) 151.30p +2.23%FTSE 250 - FallersSpirit Pub Company (SPRT) 49.50p -2.46%Catlin Group Ltd. (CGL) 417.80p -1.81%Victrex (VCT) 1,249.00p -1.73%Cranswick (CWK) 801.00p -1.72%Halfords Group (HFD) 225.50p -1.61%New World Resources A Shares (NWR) 318.60p -1.51%Barr (A.G.) (BAG) 393.60p -1.40%Ruspetro (RPO) 133.40p -1.26%easyJet (EZJ) 525.50p -1.13%Renishaw (RSW) 1,386.00p -1.00%BC
More News
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.